Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Other Working Capital Changes (2019 - 2025)

Addex Therapeutics' Other Working Capital Changes history spans 7 years, with the latest figure at $193.1 billion for Q2 2025.

  • On a quarterly basis, Other Working Capital Changes fell 59.82% to $193.1 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $12.9 billion, a 98.41% decrease, with the full-year FY2025 number at $184964.6, up 198.63% from a year prior.
  • Other Working Capital Changes came in at $193.1 billion for Q2 2025, up from -$177.8 billion in the prior quarter.
  • The five-year high for Other Working Capital Changes was $480.5 billion in Q2 2024, with the low at -$815.3 billion in Q2 2023.
  • Historically, Other Working Capital Changes has averaged $473.5 million across 5 years, with a median of $179386.7 in 2021.
  • Peak annual rise in Other Working Capital Changes hit 68350259.46% in 2023, while the deepest fall reached 704782806.87% in 2023.
  • Year by year, Other Working Capital Changes stood at $243087.9 in 2021, then skyrocketed by 133.69% to $568069.9 in 2022, then skyrocketed by 68350259.46% to $388.3 billion in 2023, then crashed by 43.86% to $218.0 billion in 2024, then decreased by 11.44% to $193.1 billion in 2025.
  • Business Quant data shows Other Working Capital Changes for ADXN at $193.1 billion in Q2 2025, -$177.8 billion in Q1 2025, and $218.0 billion in Q4 2024.